Elypta

Recent Finacing

Series A

Recent Raise

$21M

Elypta operates a metabolism-based liquid biopsy platform that measures the GAGome in blood and urine, supplying laboratory kits and analytics software with algorithms for multi-cancer detection and kidney cancer recurrence.